RØYRVIK ET AL.Roche PC, Smith DI, Thibodeau SN. Mutations <strong>in</strong> AXIN2 cause colorectalcancer with defective mismatch repair by activat<strong>in</strong>g beta-caten<strong>in</strong>/TCF signall<strong>in</strong>g.Nat Genet. 2000;26:146–7.69. Thorstensen L, L<strong>in</strong>d GE, Lovig T, Diep CB, Mel<strong>in</strong>g GI, Rognum TO, LotheRA. Genetic <strong>and</strong> epi<strong>genetic</strong> changes of components affect<strong>in</strong>g the WNT pathway<strong>in</strong> colorectal carc<strong>in</strong>omas stratified by microsatellite <strong>in</strong>stability. Neoplasia.2005;7:99–108.70. Chung YJ, Park SW, Song JM, Lee KY, Seo EJ, Choi SW, Rhyu MG. Evidenceof <strong>genetic</strong> progression <strong>in</strong> human gastric carc<strong>in</strong>omas with microsatellite<strong>in</strong>stability. Oncogene. 1997;15:1719–26.71. Yamamoto H, Sawai H, Perucho M. Frameshift somatic mutations <strong>in</strong> gastro<strong>in</strong>test<strong>in</strong>alcancer of the microsatellite mutator phe<strong>no</strong>type. Cancer Res.1997;57:4420–6.72. Catasus L, Matias-Guiu X, Mach<strong>in</strong> P, Mu<strong>no</strong>z J, Prat J. BAX somatic frameshiftmutations <strong>in</strong> endometrioid ade<strong>no</strong>carc<strong>in</strong>omas of the endometrium: evidence fora tumor progression role <strong>in</strong> endometrial carc<strong>in</strong>omas with microsatellite <strong>in</strong>stability.Lab Invest. 1998;78:1439–44.73. Fujiwara T, Stolker JM, Watanabe T, Rashid A, Longo P, Eshleman JR,Booker S, Lynch HT, Jass JR, Green JS, Kim H, Jen J, Vogelste<strong>in</strong> B, HamiltonSR. Accumulated clonal <strong>genetic</strong> <strong>alterations</strong> <strong>in</strong> familial <strong>and</strong> sporadic colorectalcarc<strong>in</strong>omas with widespread <strong>in</strong>stability <strong>in</strong> microsatellite sequences. Am JPathol. 1998;153:1063–78.74. Oliveira C, Seruca R, Seixas M, Sobr<strong>in</strong>ho-Simoes M. The cl<strong>in</strong>icopathologicalfeatures of gastric carc<strong>in</strong>omas with microsatellite <strong>in</strong>stability may be mediatedby mutations of different "target genes": a study of the TGFbeta RII, IGFII R,<strong>and</strong> BAX genes. Am J Pathol. 1998;153:1211–9.75. Ott<strong>in</strong>i L, Falchetti M, D'Amico C, Amorosi A, Saieva C, Masala G, Frati L,Cama A, Palli D, Mariani-Costant<strong>in</strong>i R. Mutations at cod<strong>in</strong>g mo<strong>no</strong>nucleotiderepeats <strong>in</strong> gastric cancer with the microsatellite mutator phe<strong>no</strong>type. Oncogene.1998;16:2767–72.76. Ouyang H, Furukawa T, Abe T, Kato Y, Horii A. The BAX gene, the promoterof apoptosis, is mutated <strong>in</strong> <strong>genetic</strong>ally unstable cancers of the colorectum,stomach, <strong>and</strong> endometrium. Cl<strong>in</strong> Cancer Res. 1998;4:1071–4.77. Percesepe A, Kristo P, Aaltonen LA, Ponz de LM, de la CA, Peltomaki P.Mismatch repair genes <strong>and</strong> mo<strong>no</strong>nucleotide tracts as mutation targets <strong>in</strong> colorectaltumors with different degrees of microsatellite <strong>in</strong>stability. Oncogene.1998;17:157–63.78. Sakao Y, Noro M, Sek<strong>in</strong>e S, Nozue M, Hirohashi S, Itoh T, Noguchi M. Microsatellite<strong>in</strong>stability <strong>and</strong> frameshift mutations <strong>in</strong> the Bax gene <strong>in</strong> hereditary<strong>no</strong>npolyposis colorectal carc<strong>in</strong>oma. Jpn J Cancer Res. 1998;89:1020–7.248
TARGET GENES OF MSI COLORECTAL CANCER79. Simms LA, Radford-Smith G, Biden KG, Buttenshaw R, Cumm<strong>in</strong>gs M, JassJR, Young J, Meltzer SJ, Leggett BA. Reciprocal relationship between the tumorsuppressors p53 <strong>and</strong> BAX <strong>in</strong> primary colorectal cancers. Oncogene.1998;17:2003–8.80. Wu MS, Lee CW, Shun CT, Wang HP, Lee WJ, Sheu JC, L<strong>in</strong> JT. Cl<strong>in</strong>icopathologicalsignificance of altered loci of replication error <strong>and</strong> microsatellite<strong>in</strong>stability-associated mutations <strong>in</strong> gastric cancer. Cancer Res. 1998;58:1494–7.81. Yagi OK, Akiyama Y, Nomizu T, Iwama T, Endo M, Yuasa Y. Proapoptoticgene BAX is frequently mutated <strong>in</strong> hereditary <strong>no</strong>npolyposis colorectal cancersbut <strong>no</strong>t <strong>in</strong> ade<strong>no</strong>mas. Gastroenterology. 1998;114:268–74.82. Yamamoto H, Sawai H, Weber TK, Rodriguez-Bigas MA, Perucho M. Somaticframeshift mutations <strong>in</strong> DNA mismatch repair <strong>and</strong> proapoptosis genes <strong>in</strong> hereditary<strong>no</strong>npolyposis colorectal cancer. Cancer Res. 1998;58:997–1003.83. Abdel-Rahman WM, Georgiades IB, Curtis LJ, Arends MJ, Wyllie AH. Roleof BAX mutations <strong>in</strong> mismatch repair-deficient colorectal carc<strong>in</strong>ogenesis. Oncogene.1999;18:2139–42.84. Bertoni F, Codegoni AM, Furlan D, Tibiletti MG, Capella C, Brogg<strong>in</strong>i M.CHK1 frameshift mutations <strong>in</strong> <strong>genetic</strong>ally unstable colorectal <strong>and</strong> endometrialcancers. Genes Chromosomes Cancer. 1999;26:176–80.85. Duval A, Iacopetta B, Ranzani GN, Lothe RA, Thomas G, Hamel<strong>in</strong> R. Variablemutation frequencies <strong>in</strong> cod<strong>in</strong>g repeats of TCF-4 <strong>and</strong> other target genes <strong>in</strong> colon,gastric <strong>and</strong> endometrial carc<strong>in</strong>oma show<strong>in</strong>g microsatellite <strong>in</strong>stability. Oncogene.1999;18:6806–9.86. Iacopetta BJ, Soong R, House AK, Hamel<strong>in</strong> R. Gastric carc<strong>in</strong>omas with microsatellite<strong>in</strong>stability: cl<strong>in</strong>ical features <strong>and</strong> mutations to the TGF-beta type IIreceptor, IGFII receptor, <strong>and</strong> BAX genes. J Pathol. 1999;187:428–32.87. Schwartz S Jr, Yamamoto H, Navarro M, Maestro M, Reventos J, Perucho M.Frameshift mutations at mo<strong>no</strong>nucleotide repeats <strong>in</strong> caspase-5 <strong>and</strong> other targetgenes <strong>in</strong> endometrial <strong>and</strong> gastro<strong>in</strong>test<strong>in</strong>al cancer of the microsatellite mutatorphe<strong>no</strong>type. Cancer Res. 1999;59:2995–3002.88. Abe Y, Masuda H. Genetic <strong>alterations</strong> of sporadic colorectal cancer with microsatellite<strong>in</strong>stability, especially characteristics of primary multiple colorectalcancers. J Surg Oncol. 2000;74:249–56.89. Barnetson R, Jass J, Tse R, Eckste<strong>in</strong> R, Rob<strong>in</strong>son B, Schnitzler M. Mutationsassociated with microsatellite unstable colorectal carc<strong>in</strong>omas exhibit widespread<strong>in</strong>tratumoral heterogeneity. Genes Chromosomes Cancer. 2000;29:130–6.90. Cal<strong>in</strong> GA, Gafa R, Tibiletti MG, Herlea V, Becheanu G, Cavazz<strong>in</strong>i L, Barbanti-Broda<strong>no</strong> G, Nenci I, Negr<strong>in</strong>i M, Lanza G. Genetic progression <strong>in</strong> microsatellite249
- Page 1 and 2:
Novel genetic and epigenetic altera
- Page 3 and 4:
TABLE OF CONTENTSACKNOWLEDGEMENTS .
- Page 5 and 6:
ACKNOWLEDGEMENTSThe present work ha
- Page 7 and 8:
Prefacetechnology[3]. This new tech
- Page 10 and 11:
SummaryThe subgroup of carcinomas w
- Page 12 and 13:
Introduction“Epigenetic inheritan
- Page 14 and 15:
Introductionamino acid change it is
- Page 16 and 17:
Introductionmethylation during embr
- Page 18 and 19:
IntroductionDNA is most of the time
- Page 20 and 21:
IntroductionFigure 5. DNA methylati
- Page 22 and 23:
IntroductionFigure 6. Incidence rat
- Page 24 and 25:
IntroductionFigure 8. Tumor staging
- Page 26 and 27:
Introductioninasmuch as 80% of colo
- Page 28 and 29:
IntroductionInstabilities involved
- Page 30 and 31:
Introductionthere seems to be a fid
- Page 32 and 33:
Introductionsevere alterations are
- Page 34 and 35:
Introductionpopulation-wide screeni
- Page 36 and 37:
IntroductionFigure 12. Present and
- Page 38 and 39:
RESULTS IN BRIEFPaper Ia. “DNA hy
- Page 40 and 41:
Results in Briefinstability, and se
- Page 42 and 43:
Results in BriefUnivariate survival
- Page 44 and 45:
Discussionseveral factors, and full
- Page 46 and 47:
Discussionlow threshold, we increas
- Page 48 and 49:
DiscussionIt may seem like unnecess
- Page 50 and 51:
Discussionthan 96% DHPLC do not sta
- Page 52 and 53:
DiscussionFigure 13. Mutation detec
- Page 54 and 55:
DiscussionClinical impact of molecu
- Page 56 and 57:
Discussionmarkers with a very high
- Page 58 and 59:
Discussionchromosomes in metaphase[
- Page 60 and 61:
DiscussionThese examples underline
- Page 62 and 63:
Discussiongenes. One is based on mu
- Page 64 and 65:
CONCLUSIONSWe have identified novel
- Page 66 and 67:
Future PerspectivesMolecular risk a
- Page 68 and 69:
REFERENCES1. Breasted J (1930) The
- Page 70 and 71:
References29. Deng G, Chen A, Pong
- Page 72 and 73:
References57. Al-Sukhni W, Aronson
- Page 74 and 75:
References84. Kunkel TA (1993) Nucl
- Page 76 and 77:
ReferencesLeggett B, Levine J, Kim
- Page 78 and 79:
References133. Lind GE, Thorstensen
- Page 80 and 81:
References156. Meling GI, Lothe RA,
- Page 82 and 83:
ReferencesT, Song X, Day RH, Sledzi
- Page 84 and 85:
References196. Honda S, Haruta M, S
- Page 86 and 87:
ORIGINAL ARTICLESAPPENDIXAppendix I
- Page 89 and 90:
GASTROENTEROLOGY 2007;132:1631-1639
- Page 91:
Paper IbGuro E Lind, Terje Ahlquist
- Page 94 and 95:
Journal of Translational Medicine 2
- Page 96 and 97:
Journal of Translational Medicine 2
- Page 98 and 99:
Journal of Translational Medicine 2
- Page 100 and 101:
Journal of Translational Medicine 2
- Page 102 and 103:
Journal of Translational Medicine 2
- Page 105:
Paper IITerje Ahlquist, Guro E Lind
- Page 108 and 109:
BackgroundMost cases of colorectal
- Page 110 and 111:
ADAMTS1 CDKN2A CRABP1 HOXA9 MAL MGM
- Page 112 and 113:
pseudogene, leading to a high rate
- Page 114 and 115:
strands. Proc Natl Acad Sci U S A 1
- Page 116 and 117:
concomitant absence of transcript a
- Page 119 and 120:
Volume 10 Number 7 July 2008 pp. 68
- Page 121 and 122:
682 RAS Signaling in Colorectal Car
- Page 123 and 124:
684 RAS Signaling in Colorectal Car
- Page 125 and 126:
686 RAS Signaling in Colorectal Car
- Page 127:
Table W2. Detailed Somatic Events o
- Page 131 and 132: Identification of RCC2 as a prognos
- Page 133 and 134: INTRODUCTIONMicrosatellite instabil
- Page 135 and 136: unselected series of primary tumors
- Page 137 and 138: specificity, i.e. that they only am
- Page 139 and 140: On the assumption that DNA repair a
- Page 141 and 142: In order to ensure that gene mutati
- Page 143 and 144: Figure 2. Mutation frequency differ
- Page 145 and 146: and TAF1B (0.50), ACVR2A and ASTE1
- Page 147 and 148: Multivariate analysesA multivariate
- Page 149 and 150: When comparing our findings of muta
- Page 151 and 152: The test series included a low numb
- Page 153 and 154: entering M-phase remains to be seen
- Page 155 and 156: 12. Duval A, Reperant M, Hamelin R
- Page 157 and 158: 34. Martineau-Thuillier S, Andreass
- Page 159: AppendicesAppendix I:List of abbrev
- Page 163 and 164: Critical Reviews TM in Oncogenesis,
- Page 165 and 166: TARGET GENES OF MSI COLORECTAL CANC
- Page 167 and 168: TARGET GENES OF MSI COLORECTAL CANC
- Page 169 and 170: TARGET GENES OF MSI COLORECTAL CANC
- Page 171 and 172: TARGET GENES OF MSI COLORECTAL CANC
- Page 173 and 174: TARGET GENES OF MSI COLORECTAL CANC
- Page 175 and 176: TARGET GENES OF MSI COLORECTAL CANC
- Page 177 and 178: TARGET GENES OF MSI COLORECTAL CANC
- Page 179 and 180: TARGET GENES OF MSI COLORECTAL CANC
- Page 181: TARGET GENES OF MSI COLORECTAL CANC
- Page 185 and 186: TARGET GENES OF MSI COLORECTAL CANC
- Page 187 and 188: TARGET GENES OF MSI COLORECTAL CANC
- Page 189 and 190: TARGET GENES OF MSI COLORECTAL CANC
- Page 191: TARGET GENES OF MSI COLORECTAL CANC